Verition Fund Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,043
Closed -$48.7K 3026
2025
Q4
$48.7K Sell
22,043
-187
-0.8% -$352 ﹤0.01% 3384
2025
Q3
$36K Hold
22,230
﹤0.01% 3672
2025
Q2
$57.6K Buy
+22,230
New +$87.7K ﹤0.01% 3521
2024
Q2
Sell
-15,730
Closed -$146K 3150
2024
Q1
$146K Buy
+15,730
New +$184K ﹤0.01% 2542

Other funds holding LUNG

Verition Fund Management's LUNG Position: Q1 2026 in Review

Verition Fund Management sold out of Pulmonx (LUNG) in Q1 2026, closing a stake of 22,043 shares — an estimated $48.7K sold.

Verition Fund Management first reported a position in LUNG in Q1 2024 and held it in 4 quarters. The position peaked at $146K in Q1 2024. 114 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Verition Fund Management reported no remaining Pulmonx position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 22,043 Pulmonx shares in Q1 2026, an estimated $48.7K.
  • Verition Fund Management first reported a position in Pulmonx in Q1 2024 and held it in 4 quarters.
  • Verition Fund Management's Pulmonx position peaked at $146K in Q1 2024.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.